Basic Information

With the ageing of the world population, the incidence of neurodegenerative diseases is on the rise. At present, an estimated 47 million people are suffering from Alzheimer’s disease and related disorders, the most prevalent class of neurodegenerative diseases. This figure shows no signs of abating, and is expected to double every 20 years as the population ages. One of the greatest challenges for neurodegenerative diseases treatment is the deciphering of the large variability – in origins, mechanisms and clinical expression – that these debilitating diseases are characterised by. With this in mind, JPND has identified a pressing need for investment aimed at enabling research projects on Personalised Medicine, that may in time bring about the delivery of targeted and timely prevention and therapies for patients of neurodegenerative diseases.

Aim of the joint call The aim of the call is to establish a limited number of ambitious, innovative, multi-national and multi-disciplinary collaborative research projects that address health and social care delivery at the macro level (system and infrastructures) as well as (at) the individual level of patients, their carers and families. Evaluating the strengths and weaknesses of formal and informal care approaches and existing infrastructures is a prelude to implementing improved, evidence-based approaches and thereby improving the quality of life for those affected by neurodegenerative diseases and the quality of care.
Type of joint call Two Stages - Call with pre-proposals and full proposals submissions
Launch date 07/01/2019
Deadline Pre-Proposal 12/03/2019 Submitted proposal: 180
Deadline Full-Proposal 25/06/2019 Submitted proposal: 38
Evaluation End Date n/a Successful proposal: n/a Proposals funded: 18
Is call co-funded? Yes
Call follow up funding n/a
Call reasons n/a
Research fields
  • Health
Type of research n/a
Target groups
  • Higher Education Institutions (HEIs)
  • Public Research Organisations (PROs)
  • SME (Small and Medium Enterprises)
Participating networks

Organisations Participating

Country Organisation
Australia National Health and Medical Research Council (NHMRC)
Belgium National Fund for Scientific Research (FNRS)
Belgium Research Foundation Flanders (FWO)
Canada Canadian Institutes of Health Research (CIHR)
Czech Republic Ministry of Education Youth and Sports (MEYS-MSMT)
Denmark Innovation Fund Denmark (Innofond)
Denmark The Velux Foundations (VELUX)
Finland Academy of Finland (AKA)
France National Research Agency (ANR)
Germany Federal Ministry of Education and Research (BMBF)
Hungary National Research, Development and Innovation Office (NKFIH)
Ireland Health Research Board (HRB)
Israel Ministry of Health (CSO-MOH)
Italy Ministry of Education, University and Research (MIUR)
Italy Ministry of Health (MOH/MDS)
Latvia State Education Development Agency (VIAA)
Luxembourg National Fund for Research (FNR)
Netherlands The Netherlands Organisation for Health Research and Development (ZonMw)
Norway Research Council of Norway (RCN)
Poland National Science Centre (NCN)
Portugal Foundation for Science and Technology (FCT)
Portugal Regional Fund for Science and Technology (FRCT)
Romania Ministry of Education, Research and Innovation (MERI)
Slovenia Ministry of Education, Science, Culture and Sport (MESCS/MIZS)
Spain Institute of Health Carlos III (ISCIII)
Sweden Swedish Research Council (VR/SRC)
Türkiye The Scientific and Technological Research Council of Turkey (TUBITAK)
United Kingdom Medical Research Council (MRC)
United Kingdom United Kingdom Research and Innovation (UKRI)

Funded Projects

Acronym Title Start End No. partners
ADAIR From air pollution to brain pollution – novel biomarkers to ... 8
DIPPA-FTD Diagnostic and Prognostic Precision medicine Algorithm for b... 5
E-DADS Early Detection of Alzheimer’s Disease Subtypes 6
EU-FINGERS EURO-FINGERS multimodal precision prevention toolbox for dem... 8
GBA-PaCTS GBA – personalised medicine for Parkinson disease: clinical ... 6
GENFI-prox Defining measures of proximity to symptom onset in the GENet... 6
Gums&Brain Alzheimer’s disease as a co-morbidity of chronic periodontit... 5
MIDDEL Music Interventions for Dementia and Depression in ELderly c... 5
NMJ-Chip Humanized high-throughput co-culture system for motor neuron... 8
ORGTHERAPY Multicellular organoids: modeling, mechanisms and therapy de... 6
OligoFIT Oligomer-Focused screening and Individualized Therapeutics t... 6
PMG-AD Personalized medicine approach for novel microglia-associate... 5
PMI-AD Precision Medicine Interventions in Alzheimer’s Disease 7
PREADAPT Identification of personalized inflammatory profiles of agin... 7
SORLA-FIX Identifying and treating SORL1-associated Alzheimer’s disease 5
STRATALS Stratification of presymptomatic amyotrophic lateral scleros... 5
TRIAGE TRanslating Individual Alzheimer GEnetic risk into disease p... 4
bPRIDE blood PRotein Identification to Discriminate dEmentias 7